Biologic Role of Cytomegalovirus in Endothelial Cell Inflammation and Atheroscler

巨细胞病毒在内皮细胞炎症和动脉粥样硬化中的生物学作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The significance of this proposal is that it focuses on cardiovascular diseases which represent a leading cause of mortality in industrialized nations. Atherosclerosis preferentially develops in regions of the arterial tree with branches and curvatures where blood flow is disturbed and shear stress is low and non- uniform. There is increasing evidence that laminar blood flow with high shear stress modulates gene expression in endothelial cells (ECs) to protect against atherosclerosis, inflammation and coagulation, and that disturbed flow upregulates proatherosclerotic, proinflammatory, and procoagulant genes. It has long been suspected that human cytomegalovirus (HCMV) infection is a risk factor for vascular disease such as atherosclerosis and restenosis following angioplasty. The key question is what is the mechanism underlying HCMV's role in the disease process? Many studies have shown that HCMV infection induces proatherogenic gene expression in ECs, smooth muscle cells and monocytes/macrophages, but all these studies were performed in static cell culture, where there is no flow or shear stress. The Deborah Spector lab is the first t study HCMV infection of aortic ECs exposed to varying conditions of flow and shear stress. We hypothesize that flow conditions affect HCMV interaction with ECs and that this in turn modulates the EC functions and interactions with leukocytes, and smooth muscle cells to lead to lesion formation. Detailed knowledge of HCMV pathogenesis as well as in vivo animal models are required in order to address questions regarding the HCMV infection in EC inflammation. The novelty of this proposal is that it addresses the roles of HCMV infection and flow dyamics in atherosclerosis by an interdisciplinary approach. It brings together the extensive expertise in the Deborah Spector lab on molecular and cellular biology of HCMV and MCMV, the broad experience in the Stephen Spector lab on HCMV pathogenesis and translational medicine, and the vast knowledge and technical expertise of Joseph Witztum on the in vivo pathogenesis of atherosclerosis to test our hypothesis and assess the potential role of HCMV in atherosclerosis. Three Specific Aims are proposed. In Aim 1, we will determine the bi-directional interactions between HCMV and ECs under high vs. low shear stress (HSS vs. LSS). In Aim 2, we will determine the effect of HCMV infection of ECs on adhesion and transendothelial migration of Immunologically primed and na�ve PBMCs under conditions of HSS and LSS. In Aim 3, we will utilize in vivo studies to define the impact of MCMV on the ApoE-/- mouse model of atherosclerosis. The long- term objective of this proposal is to provide novel insights into the pathogenesis of atherosclerosis. Accomplishment of this goal will facilitate the development of new strategies designed to prevent and treat atherosclerotic disease.
描述(由申请人提供):该提案的重要性在于,它侧重于心血管疾病,这是工业化国家死亡的主要原因。动脉粥样硬化优先发展在具有分支和弯曲的动脉树的区域中,其中血流受到干扰并且剪切应力低且不均匀。越来越多的证据表明,层流高切应力调节内皮细胞(EC)的基因表达,以防止动脉粥样硬化,炎症和凝血,和干扰流上调促动脉粥样硬化,促炎症和促凝血基因。人巨细胞病毒(human cytomegalovirus,HCMV)感染是血管疾病如动脉粥样硬化和血管成形术后再狭窄的危险因素。关键问题是HCMV在疾病过程中的作用机制是什么?许多研究表明,HCMV感染诱导内皮细胞,平滑肌细胞和单核细胞/巨噬细胞中的致动脉粥样硬化基因表达,但所有这些研究都是在静态细胞培养中进行的,其中没有流动或剪切应力。Deborah Spector实验室是第一个研究暴露于不同流动和剪切应力条件下的主动脉内皮细胞的HCMV感染的实验室。我们假设,流动条件影响HCMV与EC的相互作用,这反过来又调节EC功能和与白细胞和平滑肌细胞的相互作用,导致病变形成。为了解决EC炎症中HCMV感染的问题,需要详细了解HCMV发病机制以及体内动物模型。该提案的新奇在于,它通过跨学科的方法解决了HCMV感染和血流动力学障碍在动脉粥样硬化中的作用。它汇集了广泛的专业知识, Deborah Spector实验室对HCMV和MCMV的分子和细胞生物学,Stephen Spector实验室对HCMV发病机制和转化医学的广泛经验,以及Joseph Witztum对动脉粥样硬化体内发病机制的丰富知识和技术专长,以验证我们的假设并评估HCMV在动脉粥样硬化中的潜在作用。提出了三个具体目标。在目标1中,我们将确定HCMV和EC之间的双向相互作用在高与低剪切应力(HSS与LSS)。在目的2中,我们将确定在HSS和LSS条件下,内皮细胞的HCMV感染对免疫致敏和幼稚PBMC的粘附和跨内皮迁移的影响。在目标3中,我们将利用体内研究来确定MCMV对ApoE-/-小鼠动脉粥样硬化模型的影响。长期的目标是为动脉粥样硬化的发病机制提供新的见解.这一目标的实现将促进旨在预防和治疗动脉粥样硬化疾病的新策略的发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEBORAH Hye SPECTOR其他文献

DEBORAH Hye SPECTOR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEBORAH Hye SPECTOR', 18)}}的其他基金

Zika Virus Pathogenesis and Selective Autophagy Induction to Inhibit Virus Production
寨卡病毒发病机制和选择性自噬诱导抑制病毒产生
  • 批准号:
    9277152
  • 财政年份:
    2017
  • 资助金额:
    $ 54.53万
  • 项目类别:
Viral Pathogenesis and Atherosclerosis
病毒发病机制和动脉粥样硬化
  • 批准号:
    8769089
  • 财政年份:
    2014
  • 资助金额:
    $ 54.53万
  • 项目类别:
Role of CMV in Heart Disease of HIV-Infected Women and Perinatally Infected Youth
CMV 在 HIV 感染妇女和围产期感染青少年心脏病中的作用
  • 批准号:
    8915898
  • 财政年份:
    2014
  • 资助金额:
    $ 54.53万
  • 项目类别:
Disruption of Neural Stem Cell Homeostasis by Cytomegalovirus
巨细胞病毒破坏神经干细胞稳态
  • 批准号:
    8570815
  • 财政年份:
    2013
  • 资助金额:
    $ 54.53万
  • 项目类别:
Disruption of Neural Stem Cell Homeostasis by Cytomegalovirus
巨细胞病毒破坏神经干细胞稳态
  • 批准号:
    8661325
  • 财政年份:
    2013
  • 资助金额:
    $ 54.53万
  • 项目类别:
CMV 2012 - combined 4th Congenital Cytomegalovirus Conference and 14th Internatio
CMV 2012 - 第四届先天性巨细胞病毒会议和第 14 届国际巨细胞病毒会议合并
  • 批准号:
    8400272
  • 财政年份:
    2012
  • 资助金额:
    $ 54.53万
  • 项目类别:
Atherosclerosis: Cytomegalovirus, Shear Stress, and Endothelial Cells
动脉粥样硬化:巨细胞病毒、剪切应力和内皮细胞
  • 批准号:
    8192010
  • 财政年份:
    2011
  • 资助金额:
    $ 54.53万
  • 项目类别:
Atherosclerosis: Cytomegalovirus, Shear Stress, and Endothelial Cells
动脉粥样硬化:巨细胞病毒、剪切应力和内皮细胞
  • 批准号:
    8269800
  • 财政年份:
    2011
  • 资助金额:
    $ 54.53万
  • 项目类别:
Development of a Novel Vaccine Against Herpes Simplex Type 2
新型 2 型单纯疱疹疫苗的开发
  • 批准号:
    7914756
  • 财政年份:
    2009
  • 资助金额:
    $ 54.53万
  • 项目类别:
Disabling of the Anaphase Promoting Complex by Human Cytomegalovirus
人巨细胞病毒使后期促进复合物失活
  • 批准号:
    7712782
  • 财政年份:
    2009
  • 资助金额:
    $ 54.53万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.53万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.53万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.53万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 54.53万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 54.53万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 54.53万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 54.53万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 54.53万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 54.53万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 54.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了